Tag: Colin Hayward

Top Physician to Lead Cell-Based Therapy Panel at Clin Ops West

DURHAM, N.C., April 25, 2019 — Premier Research will moderate a panel on cell-based therapies on Tuesday, April 30, at the Clinical Operations in Oncology Trials West Coast meeting in Burlingame, Calif. Colin Hayward, the company’s chief medical officer, will lead a discussion about how researchers are overcoming the challenges inherent in creating cell-based cancer...

Medical and Regulatory Affairs

Chief Medical Officer Discussing Early Regulatory Engagement at OCT Southern California

DURHAM, N.C., November 2, 2018 — Premier Research’s Chief Medical Officer will discuss bridging the regulatory engagement gap from pre-clinical to first patient in at Outsourcing in Clinical Trials New England, November 6, in Boston. Dr. Colin Hayward will address strategic and practical considerations for engaging with regulatory bodies on the opening day of the annual...

Chief Medical Officer Discussing Immuno-Oncology Molecules at OCT Southern California

DURHAM, N.C., SEPTEMBER 25, 2017 — Premier Research’s Chief Medical Officer will discuss development of immuno-oncology molecules at Outsourcing in Clinical Trials Southern California, September 27-28 in La Jolla. Dr. Colin Hayward will address strategic and practical considerations for molecule development on the opening day of the annual gathering of pharma, biotech, and medical device leaders....

Consulting

Brexit: Bust or Boon for the Clinical Trials Industry?

Article 50 was triggered on March 29, 2017, and officially started the two-year negotiation period before the U.K. exits the European Union. The uncertainty of Brexit has left researchers and others in the clinical trials industry nervous about their future. Many of the largest changes for researchers in the U.K. depend on what happens during the next...

Consulting

From Lab to Bedside: February 28 Webinar Examines Treatment of Rare Cancers

DURHAM, N.C., FEBRUARY 22, 2017 — Premier Research will share new insights on rare oncology drug development at a webinar on Tuesday, February 28. From Laboratory to Bedside: Expediting Development of Novel Rare Cancer Treatments (11 a.m. EST / 4 p.m. GMT / 5 p.m. CET) will examine how new processes and regulatory pathways are...

Consulting

Premier Research Sponsors, Presents at OCT West Coast in February

DURHAM, N.C., February 20, 2017 — Premier Research is a presenting sponsor of this year’s Outsourcing in Clinical Trials West Coast conference in Burlingame, California, and two company executives are speaking at the event. Dr. Colin Hayward, Chief Medical Officer, will speak on moving oncology molecules to proof of concept on Wednesday, February 22, at...

Clinical Research: Phase 1 - Phase 4

Informed Strategy Key to Drug Development Innovation, Premier Research Says in Naming Regulatory Chief

DURHAM, N.C., June 27, 2016 — Small biotechnology companies taking new biopharmaceutical products from benchtop to bedside need an informed regulatory strategy and a close working knowledge of the Food and Drug Administration and other regulatory agencies. So when it sought a new head of regulatory affairs, clinical development service provider Premier Research found its ideal...

Premier Research Names Dr. Colin Hayward Chief Medical Officer

PHILADELPHIA, November 23, 2015 — Premier Research announces the appointment of Dr. Colin Hayward, FFPM, as Chief Medical Officer. Dr. Hayward is Premier Research’s top medical expert, providing global leadership for patient safety, scientific and ethical governance, and delivery of high-quality customer service. Dr. Hayward embodies a rare combination of business and scientific expertise. After...